CID 146609022

Lotiglipron

Structural Information

Molecular Formula
C31H31ClN4O5
SMILES
C[C@@]1(OC2=CC=CC(=C2O1)C3CCN(CC3)CC4=NC5=C(N4C[C@@H]6CCO6)C=C(C=C5)C(=O)O)C7=NC=C(C=C7)Cl
InChI
InChI=1S/C31H31ClN4O5/c1-31(27-8-6-21(32)16-33-27)40-26-4-2-3-23(29(26)41-31)19-9-12-35(13-10-19)18-28-34-24-7-5-20(30(37)38)15-25(24)36(28)17-22-11-14-39-22/h2-8,15-16,19,22H,9-14,17-18H2,1H3,(H,37,38)/t22-,31-/m0/s1
InChIKey
SVPYZAJTWFQTSM-UGDMGKLASA-N
Compound name
2-[[4-[(2S)-2-(5-chloropyridin-2-yl)-2-methyl-1,3-benzodioxol-4-yl]piperidin-1-yl]methyl]-3-[[(2S)-oxetan-2-yl]methyl]benzimidazole-5-carboxylic acid
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

119
Patents

574.1983 Da
Monoisotopic Mass

1.9
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 575.20558 224.5
[M+Na]+ 597.18752 230.0
[M-H]- 573.19102 236.2
[M+NH4]+ 592.23212 219.6
[M+K]+ 613.16146 229.8
[M+H-H2O]+ 557.19556 207.9
[M+HCOO]- 619.19650 226.2
[M+CH3COO]- 633.21215 229.7
[M+Na-2H]- 595.17297 218.6
[M]+ 574.19775 236.6
[M]- 574.19885 236.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe